Skip to main content
Log in

Counting costs of chronic vs episodic migraine in the US

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. funded by Allergan plc, Ireland

  2. a two-phase, web-based, cross-sectional panel survey conducted in 10 countries, including the US, between February and April 2009

Reference

  • Messali A, et al. Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey. Headache : Feb 2016. Available from: URL: http://doi.org/10.1111/head.12755

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Counting costs of chronic vs episodic migraine in the US. PharmacoEcon Outcomes News 748, 12 (2016). https://doi.org/10.1007/s40274-016-2863-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-2863-1

Navigation